Peptide Therapy Adults Over 60: Who Is and Is Not a Candidate Strong Candidates Adults 60+ with documented low IGF-1 on serum testing Individuals with sarcopenia confirmed by DEXA or functional testing Active seniors experiencing delayed recovery, poor sleep, and reduced energy not explained by other pathology Adults managing visceral obesity with inadequate response to diet and exercise Individuals already on andropause or menopause hormone therapy who want adjunctive metabolic support Poor Candidates or Contraindicated Any history of active cancer (especially hormone-sensitive: prostate, breast, colon) Uncontrolled diabetes (HbA1c above 8.5%) Severe cardiac or renal impairment Active intracranial pathology (GH secretagogues stimulate pituitary
Cochrane Database Syst Rev (10):CD005590 Zhou L, Dhopeshwarkar N, Blumenthal KG, Goss F, Topaz M, Slight SP, Bates DW (2016) Drug allergies documented in electronic health records of a large healthcare system
Always consult with your healthcare provider before introducing new supplements, especially if you have a history of kidney stones or are managing complex medication regimens
When the medication is injected in the proper doses at the right intervals, the patients appetite is reduced